Regen Biopharma (RGBP) Stock Statistics & Valuation Metrics

Regen Biopharma has a market cap or net worth of $626.04K. The enterprise value is ―.

Regen Biopharma has 10,016,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Regen Biopharma’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 9.55%.

The current PE Ratio of Regen Biopharma is 0.00. Regen Biopharma’s PEG ratio is 0.00.

In the last 12 months, Regen Biopharma had revenue of 236.56K and earned -867.25K in profits. Earnings per share was -0.21.

In the last 12 months, operating cash flow was -597.18K and capital expenditures -6.00, giving a free cash flow of -597.19K billion.

Regen Biopharma pays an annual dividend of $0.057, resulting in a dividend yield of ―

Regen Biopharma upcoming earnings date is May 14, 2018, TBA Not Confirmed.

Regen Biopharma as a current ratio of 0.03, with Debt / Equity ratio of -15.59%

In the past 12 months, Regen Biopharma has paid 0.00 in taxes.

Regen Biopharma EV to EBITDA ratio is -1.95, with an EV/FCF ratio of -1.17.

Regen Biopharma has $135.00 in cash and marketable securities with $511.59K in debt, giving a net cash position of $873.00K billion.

Gross margin is 42.66%, with operating margin of -176.78%, and net profit margin of -366.61%.

The average price target for Regen Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―